Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Patent
1995-06-05
1999-10-19
Ketter, James
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
4242441, 530403, A61K 39385, A61K 3909, C07K 104
Patent
active
059685212
ABSTRACT:
A vaccine capable of protecting a recipient from infection caused by group B Streptococcus. The vaccine provides polysaccharide-protein moieties and contain (a) a group B Streptococcus polysaccharide conjugated to (b) a functional derivative of a group B Streptococcus C protein alpha antigen that retains the ability to elicit protective antibodies against group B Streptococcus. The vaccine may contain only one type of such polysaccharide-protein unit or may contain a mixture of more than one type of unit.
REFERENCES:
patent: 4207414 (1980-06-01), Kasper
patent: 4284537 (1981-08-01), Beachey
patent: 4324887 (1982-04-01), Kasper
patent: 4356170 (1982-10-01), Jennings et al.
patent: 4356263 (1982-10-01), Kasper
patent: 4367221 (1983-01-01), Kasper
patent: 4367222 (1983-01-01), Kasper
patent: 4367223 (1983-01-01), Kasper
patent: 4425330 (1984-01-01), Norcross et al.
patent: 4619828 (1986-10-01), Gordon
patent: 4673574 (1987-06-01), Anderson
patent: 4757134 (1988-07-01), Blake et al.
patent: 4761283 (1988-08-01), Anderson
patent: 4789735 (1988-12-01), Frank et al.
patent: 4830852 (1989-05-01), Marburg et al.
patent: 4902506 (1990-02-01), Anderson et al.
patent: 5302386 (1994-04-01), Kasper et al.
patent: 5648241 (1997-07-01), Michel et al.
Paoletti et al. Immunogenicity of Group B Streptococcus type III polysaccharide-tetanus toxoid vaccine in baboons. Infection and Immunity vol. 64 677-679, 1996.
Madoff et al. Maternal immunization of mice with Group B Streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes. J. Clin. Invest. vol. 94 286-292, 1994.
Anderson, B. E. et al., "A Protective Protein Antigen of Rickettsia rickettsii Has Tandemly Repeated, Near-Identical Sequences", Infect. Immun. 58(9):2760-2769 (Sep. 1990).
Avery, O. T. et al., "Chemo-Immunological Studies on Conjugated Carbohydrate-Proteins", J. Exp. Med. 54:437-447 (1931).
Baker, C.J. and Kasper, D.L., "Group B Streptococcal Vaccines," Rev. Infect. Dis. 7(4):458-467 (1985).
Baker, C. J. et al., "Immunization of Pregnant Women With A Polysaccharide Vaccine of Group B Streptococcus", New Eng. J. Med. 319(18):1180-1185 (Nov. 1988).
Baker, C.J. et al., "Immunization to Prevent Group B Streptococcal Disease: Victories and Vexations,"J. Inf. Dis. 161(5):917-921 (May 1990).
Bevanger, L. et al., "Complete and Incomplete Ibc Protein Fraction in Group B Streptococci", Acta path. microbiol. scand. Sect. B 87:51-54 (1979).
Bevanger, L. et al., "the Ibc Protein Fraction of Group B Streptococci: Characterization of Protein Antigens Extracted by HCL", Acta path. microbiol. scand. Sect. B. 89:205-209 (1981).
Bevanger, L., "Ibc Proteins as Serotype Markers of Group B Streptococci", Acta path. microbiol. immunol. scand. Sect. B 91:231-234 (1983).
Bevanger, L., "The Ibc Proteins of Group B Streptococci: Isolation of the .alpha. and .beta. Antigens by Immunosorbent Chromatography and Test for Human Serum Antibodies Against the Two Antigens", Acta path. microbiol. immunol. scand. Sect. B 93:113-119 (1985).
Bevanger, L. et al., "Mouse-Protective Antibodies Against the Ibc Proteins of Group B Streptococci", Acta path. microbiol. immunol. scand. Sect B 93:121-124 (1985).
Bevanger, L. et al., "Characterization of the antigen of the c proteins of group B streptococci (GBS) using a murine monoclonal antibodyp", Acta Pathol. Microbiol. Immunol. Scand. 100(1):57-62 (Jan. 1992).
Bittle, J. L. et al., "Vaccines Produced by Conventional Means to Control Major Infectious Diseases of Man and Animals", Adv. Vet. Sci. Comp. Med. 33:1-63 (Feb. 1989).
Boyer, K.M. et al., "Human IgG Antibody to Group B Streptococcus Type II: Protection in a Mouse Model," Clin. Res. 34(4):962A (1986).
Brady, L. J. et al., "Identification of Non-Immunoglobulin A-Fc-Binding Forms and Low-Molecular-Weight Secreted Forms of the Group B Streptococcal .beta. Antigen", Infect. Immun. 57(5):1573-1581 (May 1989).
Cleat, P. H. et al., "Cloning and Expression in Escherichia coli of the Ibc Protein Genes of Group B Streptococci: Binding of Human Immunoglobulin A to the Beta Antigen", Infect. Immun. 55(5):1151-1155 (1987).
Coleman, R. T. et al., "Prevention of Neonatal Group B Streptococcal Infections: Advances in Maternal Vaccine Development", Obst. Gynec. 80(2):301-309 (Aug. 1992).
Dailey, D. C. et al., "The Phenotypically Variable Surface Protein of Trichomonas vaginalis Has a Single, Tandemly Repeated Immunodominant Epitope", Infect. Immun. 59(6):2083-2088 (Jun. 1991).
Devi, S.J.N. et al., "Antibodies to poly[(2.fwdarw.8)-.alpha.-N-acetylneuraminic acid] and poly [(2.fwdarw.9)-.alpha.-N-acetylneuraminic acid] are elicited by immunization of mice with Escherichia coli K92 conjugates: Potential vaccines for groups B and C meningococci and E. coli K1," Proc. Natl. Acad. Sci. USA 88:7175-7179 (Aug. 1991).
Dick, W.E. Jr. and Beurret, M., "Glycoconjugates of Bacterial Carbohydrate Antigens: A Survey and Consideration of Design and Preparation Factors," in Contributions to Microbiology and Immunology, vol. 10, Cruse, J.M. and Lewis R.E. Jr., eds., Karger, Basel, Switzerland (Jul. 1989), pp. 48-114.
Dintzis, R.Z., "Rational Design of Conjugate Vaccines," Pediatr. Res. 32(4):376-385 (Oct. 1992).
Enea, V. et al., "DNA Cloning of Plasmodium falciparum Circumsporozoite Gene: Amino Acid Sequence of Repetitive Epitope", Science 225:628-630 (1984).
Feldman, R. G. et al., "The immune response to the group B streptococcus", Rev. Med. Microbiol. 3(1):52-58 (Jan. 1992).
Ferrieri, P., "Surface-Localized Protein Antigens of Group B Streptococci", Rev. Infect. Dis. 10(Suppl. 2):s363-s366 (Jul.-Aug. 1988).
Fischetti, V. A. et al., "Structure, Function, and Genetics of Streptococcal M Protein", Rev. Infect. Dis. 10(Suppl. 2):s356-s359 (Jul.-Aug. 1988).
Fischetti, V. A. et al., "Common Characteristics of the Surface Proteins from Gram-Positive Cocci", in: Genetics and Molecular Biology of Streptococci, Lactococci, and Enterococci, Dunny, G. M. et al., eds., American Society for Microbiology: Washington, D.C., pp. 290-294 (Jul. 1991).
Heden, L.-O. et al., "Molecular characterization of a IgA receptor from group B streptococci: sequence of the gene, identification of a proline-rich region with unique structure and isolation of N-terminal fragments with IgA-binding capacity", Eur. J. Immunol. 21:1481-1490 (Jun. 1991).
Heiman, H.S. and Weisman, L.E., "The Opsonic Antibody Response of Female Rats to Type III Group B Streptococcal Immunization: a Model for Maternal Immunity," Veterin. Immunol. Immunopath. 24:79-89 (Jan. 1990).
Horensky, D. S. et al., "Generation and Analysis of Group B Streptococcal Alpha C Protein Gene Constructs Containing Variable Numbers of Tandem Repeats", Abstracts of the 93rd General Meeting of the American Society for Microbiology, Session 107, Abstract D-68 (May 1993).
Insel, R. A., "Maternal Immunization to Prevent Neonatal Infections", New Eng. J. Med. 319)18):1219-1220 (Nov. 1988).
Jennings, H.J. et al., "Conformational Aspects Critical to the Immunospecificity of the Type III Group B Streptococcal Polysaccharide," Biochemistry 20(16):4511-4518 (1981).
Jennings, H.J. and Lugowski, C., "Immunochemistry of Groups A, B, and C Meningococcal Polysaccharide-Tetanus Toxoid Conjugates," J. Immunol. 127(3):1011-1018 (1981).
Jennings, H.J. et al., "Structural Determination of the Capsular Polysaccharide Antigen of Type II Group B Streptococcus," J. Biol. Chem. 258(3):1793-1798 (1983).
Jennings, H.J., "Capsular Polysaccharides as Human Vaccines," in Advances in Carbohydrate Chemistry and Biochemistry. vol. 41, Tipson, R.S. and Horton, D., eds., Academic Press, NY (1983), pp. 155-208.
Jennings, H.J. and Roy, R., "Enhancement of the Immune Response to the Group B Polysaccharide of Neisseria meningitidis by Means of Its Chemical Modification," in The Pathogenic Neisseriae: Proc. 4th Intl. Symp., Schoolnik, G.K. et al., eds., Am. Soc. Microbiol., Washington, D.C. (1985), pp. 628-632.
Jerlstrom, P. G. et al., "The IgA-binding .beta. antigen of the c protein complex of Group B streptococci: sequence determination of its gene and detection of two
Ausubel Frederick M.
Kasper Dennis L.
Madoff Lawrence C.
Michel James L.
Brigham and Women's Hospital
Brusca John S.
Ketter James
The General Hospital Corporation
LandOfFree
Conjugate vaccine for group B Streptococcus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Conjugate vaccine for group B Streptococcus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conjugate vaccine for group B Streptococcus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2052192